Bernhard Lammle

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications

Complement and transplant-associated thrombotic microangiopathy: Current and future approaches.

Complement and transplant-associated thrombotic microangiopathy: Current and future approaches.

Journal: HemaSphere
Published: March 04, 2026

Is congenital thrombotic thrombocytopenic purpura a risk factor for ischemic osteonecrosis of the hip joint (Legg-Calvé-Perthes disease)?

Is congenital thrombotic thrombocytopenic purpura a risk factor for ischemic osteonecrosis of the hip joint (Legg-Calvé-Perthes disease)?

Journal: Thrombosis journal
Published: December 06, 2025

The KLF4-CD46 axis: a novel therapeutic target in transplant-associated thrombotic microangiopathy and beyond.

The KLF4-CD46 axis: a novel therapeutic target in transplant-associated thrombotic microangiopathy and beyond.

Journal: Haematologica
Published: August 22, 2025

Correction: Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025.

Correction: Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025.

Journal: Intensive care medicine
Published: July 22, 2025

Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025.

Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025.

Journal: Intensive care medicine
Published: March 04, 2025

The third form of thrombotic thrombocytopenic purpura shows up again: what is it, does it even exist, how to find out? Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".

The third form of thrombotic thrombocytopenic purpura shows up again: what is it, does it even exist, how to find out? Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".

Journal: Haematologica
Published: February 06, 2025

A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission.

A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission.

Journal: Journal of thrombosis and haemostasis : JTH
Published: November 04, 2024

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Journal: EClinicalMedicine
Published: October 21, 2024

Vitamin B12 deficiency misdiagnosed as TTP: What can we learn from it?

Vitamin B12 deficiency misdiagnosed as TTP: What can we learn from it?

Journal: British journal of haematology
Published: July 30, 2024

The history of thrombotic thrombocytopenic purpura research: a narrative review.

The history of thrombotic thrombocytopenic purpura research: a narrative review.

Journal: Annals of blood
Published: July 25, 2024

Immune-mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report.

Immune-mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report.

Journal: British journal of haematology
Published: July 04, 2024

ADAMTS13 recovery in caplacizumab-treated TTP.

ADAMTS13 recovery in caplacizumab-treated TTP.

Journal: Blood
Published: May 02, 2024
Showing 1-12 of 99

Last Updated: 09/26/2026